Elena Biagini, MD, Arend F. L

Slides:

Advertisements

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Advertisements

An Unusual Electrocardiogram in a Heart Transplant Recipient Hamish I. MacLachlan, BSc, MBBS, Jonathan R. Dalzell, MD, MRCP The American Journal of Medicine.

Stress echocardiography for risk stratification of patients with chest pain and normal or slightly narrowed coronary arteries Riccardo Bigi, MD, FESC,

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO

Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Axel.

Effects of structured care by a pharmacist-diabetes specialist team in patients with Type 2 diabetic nephropathy Wilson Y.S. Leung, BPharm, PhD, Wing-Yee.

New-onset Atrial Fibrillation Predicts Heart Failure Progression

Heather C. Brod, MA, Stanley Lemeshow, PhD, Philip F. Binkley, MD, MPH

Sexuality The American Journal of Medicine

An Unusual Cause of Leg Ulcerations

Impact of More Restrictive Blood Transfusion Strategies on Clinical Outcomes: A Meta- analysis and Systematic Review Shelley R. Salpeter, MD, Jacob S.

Richard V. Milani, MD, Carl J. Lavie, MD, Robert M

Aruna D. Pradhan, MD, Nader Rifai, PhD, Julie E. Buring, ScD, Paul M

Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction Stein Ørn, MD, John G.F. Cleland, MD, Matti.

Predicting Survival in Oldest Old People

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

Matthew I. Worthley, MBBS, PhD, FRACP, Fiona M

Systematic Review and Meta-analysis of Adverse Events of Low-dose Aspirin and Clopidogrel in Randomized Controlled Trials Kenneth R. McQuaid, MD, Loren.

Subclinical Thyroid Disease and Mortality in the Elderly: A Retrospective Cohort Study Alon Grossman, MD, MHA, Avraham Weiss, MD, Nira Koren-Morag, PhD,

Prognostic Value of Low Blood Glucose at the Presentation of E

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Overview of Current Learning Theories for Medical Educators

Incidence and Mortality Rates of Syncope in the United States

Pyogenic Liver Abscess as the Initial Manifestation of Underlying Hepatocellular Carcinoma Yi-Tsung Lin, MD, Chia-Jen Liu, MD, Tzeng-Ji Chen, MD, Te-Li.

Prognostic Importance of Low Admission Serum Creatinine Concentration for Mortality in Hospitalized Patients Charat Thongprayoon, MD, Wisit Cheungpasitporn,

Epidemiology of Myelodysplastic Syndromes

Trend in Mortality after Stroke with Atrial Fibrillation

A Randomized, Double-Blind, Placebo-Controlled Trial of Nutritional Supplementation During Acute Illness Salah Gariballa, MD, Sarah Forster, MSc, Stephen.

The Impact of Race on the Prognosis of Preclinical Diastolic Dysfunction: A Large Multiracial Urban Population Study Jian Shan, MD, Lili Zhang, MD, MSc,

Laura Sarkisian, MD, Lotte Saaby, MD, PhD, Tina S

Reactive Hemophagocytic Syndrome in Adults: A Retrospective Analysis of 162 Patients Sébastien Rivière, MD, Lionel Galicier, MD, Paul Coppo, MD, PhD,

Peter K. Wung, MD, Janet T. Holbrook, PhD, MPH, Gary S

Antibiotic Therapy and 48-Hour Mortality for Patients with Pneumonia

Robert Goulden, MBBS, MSc, MPhil, MA The American Journal of Medicine

Laura Boucai, MD, MS, William N

A new lease on life for patients with Duchenne muscular dystrophy in Japan Fumihiko Yasuma, MD, Masaaki Konagaya, MD, Motoko Sakai, MD, Satoshi Kuru,

Stuttering Mesenteric Ischemia

The Reply The American Journal of Medicine

Gun Ownership and Firearm-related Deaths

Zachary R. McCaw, AM, Ariela R

Gout in African Americans

Matthew W. Parker, MD, Murray A. Mittleman, MD, DrPH, Carol A

Treatment of hepatitis C

Carlos Aguilar, MD, Valentin del Villar, MD

James H. O'Keefe, MD, Robert Vogel, MD, Carl J

The Obesity Paradox and Weight Loss

Repeated Hemoglobin A1C Ordering in the VA Health System

Type 1 and 2 Myocardial Infarction and Myocardial Injury: Clinical Transition to High- Sensitivity Cardiac Troponin I Yader Sandoval, MD, Stephen W. Smith,

Persistent Insomnia is Associated with Mortality Risk

The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease Harm H.H. Feringa, MD, Stefanos.

Does Methylphenidate Reduce the Symptoms of Chronic Fatigue Syndrome?

Stop Talking ‘Dirty’: Clinicians, Language, and Quality of Care for the Leading Cause of Preventable Death in the United States John F. Kelly, PhD, Sarah.

Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Axel.

Shannon M. Dunlay, MD, MS, Quinn R. Pack, MD, Randal J

Eroded Pacemaker in an Elderly Patient

M. Alan Brookhart, PhD, Jerry Avorn, MD, Jeffrey N

John-Michael Gamble, BScPharm, MSc, Dean T. Eurich, PhD, Thomas J

Heather C. Brod, MA, Stanley Lemeshow, PhD, Philip F. Binkley, MD, MPH

A Post-cure Complication

Perioperative asymptomatic cardiac damage after endovascular abdominal aneurysm repair is associated with poor long-term outcome Tamara A. Winkel, MD,

Rebecca D. Chason, Joan S. Reisch, PhD, Don C. Rockey, MD

Direct Observation of Residents: A Model for an Assessment System

Falls in Older Adults: Risk Assessment, Management and Prevention

Has mortality from acute renal failure decreased

Matthew W. Martinez, MD, Keith G. Rasmussen, MD, Paul S

Longer Lengths of Stay and Higher Risk of Mortality among Inpatients of Physicians with More Years in Practice William N. Southern, MD, MS, Eran Y. Bellin,

Toward a More Responsible News Media

David Tian, MD, Ram Jhingan Mohan, MD, Gary Stallings, MD

Significance of Comorbid Psychological Stress and Depression on Outcomes After Cardiac Rehabilitation Sergey Kachur, MD, Arthur R. Menezes, MD, Alban.

Effects of structured care by a pharmacist-diabetes specialist team in patients with Type 2 diabetic nephropathy Wilson Y.S. Leung, BPharm, PhD, Wing-Yee.

Presentation transcript:

Pacemaker stress echocardiography predicts cardiac events in patients with permanent pacemaker Elena Biagini, MD, Arend F.L. Schinkel, MD, Abdou Elhendy, MD, Jeroen J. Bax, MD, Vittoria Rizzello, MD, Ron T. van Domburg, PhD, Boudewijn J. Krenning, MD, Olaf Schouten, MD, Angelo Branzi, MD, Guido Rocchi, MD, Maarten L. Simoons, MD, Don Poldermans, MD The American Journal of Medicine Volume 118, Issue 12, Pages 1381-1386 (December 2005) DOI: 10.1016/j.amjmed.2005.04.040 Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 1 Kaplan-Meier survival curves (endpoint cardiac death) in patients without ischemia during pacing stress echocardiography versus patients with ischemia. The American Journal of Medicine 2005 118, 1381-1386DOI: (10.1016/j.amjmed.2005.04.040) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 2 Kaplan-Meier survival curves (endpoint all-cause mortality) in patients without ischemia during pacing stress echocardiography versus patients with ischemia. The American Journal of Medicine 2005 118, 1381-1386DOI: (10.1016/j.amjmed.2005.04.040) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 3 Kaplan-Meier survival curves for endpoint cardiac death (A) and all-cause mortality (B) in patients with ischemia involving only the septum and/or the apex versus patients with ischemia in the other regions. The American Journal of Medicine 2005 118, 1381-1386DOI: (10.1016/j.amjmed.2005.04.040) Copyright © 2005 Elsevier Inc. Terms and Conditions